Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/04/2839594/0/en/Ascendis-Pharma-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference-2024.html
https://www.globenewswire.com//news-release/2024/02/07/2825539/0/en/Ascendis-Pharma-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html
https://www.globenewswire.com//news-release/2024/02/07/2825181/0/en/Ascendis-Pharma-to-Participate-in-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/01/31/2821563/0/en/Ascendis-Pharma-to-Report-Full-Year-2023-Financial-Results-and-Provide-Business-Update-on-February-7-2024.html
https://www.globenewswire.com/news-release/2024/01/31/2821541/0/en/Ascendis-Pharma-Launches-2nd-TransCon-Product-YORVIPATH-Now-Available-in-Germany-and-Austria-for-Adults-with-Chronic-Hypoparathyroidism.html
https://www.globenewswire.com/news-release/2024/01/29/2818910/0/en/New-Company-Eyconis-Formed-to-Develop-Ascendis-Pharma-Ophthalmology-Assets-with-150-Million-Commitment-from-External-Investors.html
https://www.biospectrumasia.com/news/25/23547/specialised-therapeutics-ascendis-pharma-to-commercialise-endocrinology-therapies-in-australia-and-se-asia.html
https://www.globenewswire.com//news-release/2024/01/08/2805433/0/en/Vector-Pharma-FZCO-Announce-Exclusive-Distribution-Agreement-with-Ascendis-Pharma-A-S-for-Skytrofa-lonapegsomatropin-and-Yorvipath-palopegteriparatide-in-Gulf-Cooperation-Council-C.html
https://www.globenewswire.com//news-release/2024/01/08/2805903/0/en/Er-Kim-Announces-Exclusive-Distribution-Agreement-with-Ascendis-Pharma-A-S-to-Commercialize-3-Endocrinology-Disease-Treatments-Across-Central-Eastern-Europe-and-Turkey.html
https://www.globenewswire.com//news-release/2024/01/07/2805023/0/en/Ascendis-Pharma-Introduces-Vision-2030.html